Development of new piperazine tethered pyridine derivatives as inhibitors of BAD phosphorylation in human breast cancer

Dileep, N. and Pushpa, H. C. and Bhoomika, B. R. and Sindhu, M. P. and Mamatha, S. K. and Swaroop, T. R. and Goankar, Santosh L. and Rangappa, K. S. and Basappa, B. (2026) Development of new piperazine tethered pyridine derivatives as inhibitors of BAD phosphorylation in human breast cancer. Results in Chemistry, 19. p. 102907. ISSN 2211-7156

[img] Text (Full Text)
Development of new piperazine.pdf - Published Version
Download (1MB)
Official URL: https://doi.org/10.1016/j.rechem.2025.102907

Abstract

Breast cancer is a devastating disease responsible for many deaths worldwide. Although many drugs are available for its treatment, new anticancer agents are demand due to undesirable side effects of well accepted drugs. Many anticancer drugs contain piperazine and pyridine moieties. We previously discovered piperazine containing small molecule called NPB N-cyclopentyl-3-((4-(2,3-dichlorophenyl)piperazin-1-yl)(2-hydroxyphenyl) methyl) benzamide that targeted pBAD (BCL-2-associated death) in human breast cancer cells. Inspired by these molecules, we have designed new piperazine tethered pyridine compounds. The synthesized compounds were evaluated for their cytotoxic activity against MCF-7 breast cancer cells. A compound, N-(3-(6-chloro-5-methylpyridin-3-yl) phenyl)-2-(4-(2-nitrophenyl)piperazin-1-yl)acetamide (7h) showed the highest cytotoxic activity (6.15 μM) against MCF-7. A fair structure activity relationship has been discussed. The molecular modeling studies indicated that our title compounds induced cancer cell death via inhibition of phosphorylation of BCL-2-associated death (BAD) promoter. The results of these studies are presented in this article.

Item Type: Article
Uncontrolled Keywords: Pyridine, Piperazine, Breast cancer, Cytotoxic
Subjects: C Chemical Science > Chemistry
Divisions: Department of > Chemistry
Depositing User: C Swapna Library Assistant
Date Deposited: 29 Dec 2025 05:09
Last Modified: 29 Dec 2025 05:09
URI: http://eprints.uni-mysore.ac.in/id/eprint/18220

Actions (login required)

View Item View Item
uomeprints is powered by EPrints 3 which is developed by the School of Electronics and Computer Science at the University of Southampton. More information and software credits.